Your session is about to expire
← Back to Search
Cooking Intervention for Heart Disease
N/A
Recruiting
Led By Nicole M Farmer, M.D.
Research Sponsored by National Institutes of Health Clinical Center (CC)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Self-identified AA adults (defined as age greater than or equal to 18)
clinical hypertension or prehypertension
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 26 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a community-based cooking intervention to see if it affects home-cooking behaviors in African American adults at risk for heart disease.
Who is the study for?
This trial is for African American adults living in Wards 7 and 8 of Washington, D.C., who are at least 18 years old and have risk factors for heart disease like high waist-to-hip ratio, hypertension or prehypertension, prediabetes, overweight/obesity (BMI ≥25), high cholesterol, or elevated fasting glucose. Participants must speak English.
What is being tested?
The study aims to understand cooking behaviors among African Americans at risk for heart disease and test if a community-based cooking program led by a trained chef can improve home-cooking habits. The intervention includes weekly shared cooking events over six weeks with additional health assessments.
What are the potential side effects?
Since this is a dietary behavior intervention focusing on improving cooking habits rather than testing medications or medical procedures, there are no direct side effects as typically associated with clinical trials involving drugs.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am an adult over 18 years old and identify as African American.
Select...
I have high blood pressure or borderline high blood pressure.
Select...
I have been diagnosed with prediabetes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 26 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~26 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Facilitators and Barriers
Feasibility Measures
Secondary study objectives
Second Phase
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: 1/All SubjectsExperimental Treatment1 Intervention
Second phase participants
Find a Location
Who is running the clinical trial?
National Institutes of Health Clinical Center (CC)Lead Sponsor
389 Previous Clinical Trials
30,879,787 Total Patients Enrolled
Nicole M Farmer, M.D.Principal InvestigatorNational Institutes of Health Clinical Center (CC)
1 Previous Clinical Trials
80 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You reside in Wards 7 or 8 in Washington, D.C.The study is looking for 20 African American adults who live in Wards 7 or 8 of Washington, D.C. to participate in this phase.My BMI is 25 or higher, indicating I am overweight or obese.I am an adult over 18 years old and identify as African American.Your blood sugar levels are high when you haven't eaten for a while.You must be able to speak English.Your waist measurement is higher than your hip measurement.I have high blood pressure or borderline high blood pressure.I have been diagnosed with prediabetes.Your cholesterol levels are too high.
Research Study Groups:
This trial has the following groups:- Group 1: 1/All Subjects
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger